Comparative Biology and Pathogenesis of AIDS and Hepatitis B Viruses: Related but Different
- 1 November 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 10 (11) , 1409-1419
- https://doi.org/10.1089/aid.1994.10.1409
Abstract
AIDS (HIV) and hepatitis B viruses are remarkably similar in their sharing of reverse transcription, in their ancestral origins and common genetic elements, and in their modes of transmission. Both are hypermutable and exist as quasispecies due primarily to errors in reverse transcription, though there is severe restriction in the replicative competence of most hepatitis B mutants. They differ in the lack of an integrase in hepatitis B virus and in their pathogenesis in the infected host. HIV survives mainly by antigenic variability, immune evasion, and impairment of immune function though viral regulatory control elements seek to restrict fatal damage to the host. Hepatitis B virus survives primarily by mutation of e antigen/core genes that directly obviates cytotoxic T cell destruction of infected liver cells, or indirectly limits destruction of infected cells through induction of anergy in the cytotoxic T cell response. Most persons infected with hepatitis B virus recover completely while recovery from HIV infection is rare if ever. Hepatitis B is highly preventable by vaccine while HIV vaccine is still seeking a meaningful immunoprophylactic target. AIDS and hepatitis B represent an extreme example, among the viruses of man, in their close similarities but distinct differences. In depth details and perspectives are presented in this review.Keywords
This publication has 65 references indexed in Scilit:
- The HIV Vaccine ParadoxScience, 1994
- Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigenEuropean Journal of Immunology, 1994
- Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1994
- The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase CResearch in Virology, 1993
- Anti-HIV VaccinesDrugs, 1993
- p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell linesCarcinogenesis: Integrative Cancer Research, 1993
- Vaccines against hepatitis A and BJournal of Gastroenterology and Hepatology, 1993
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- Hepatitis B virusDigestive Diseases and Sciences, 1992
- Hepatitis B: global importance and need for controlVaccine, 1990